1. Home
  2. /
  3. Availability
  4. /
  5. Cost-effectiveness of routine adolescent vaccination with an M72/AS01E-like tuberculosis vaccine in South Africa and India

Cost-effectiveness of routine adolescent vaccination with an M72/AS01E-like tuberculosis vaccine in South Africa and India

Description

We estimated the impact and cost-effectiveness of six scenarios of routine adolescent M72/AS01E-like vaccination in South Africa and India.
TB vaccine theme
Availability
Economic impact/cost-effectivenss

Project details

Country
India, South Africa
Timeline
2022
Target group
Adolescents
Vaccine
M72/AS01e
Type of protection of vaccine
Prevention of disease
Type of research
Modelling
Partners involved
BMGF, LSHTM, Sanofi Pasteur
Type of project
research

Resources

Cost-effectiveness of routine adolescent vaccination with an M72/AS01E-like tuberculosis vaccine in South Africa and India.

Contact

Joeri Buis
joeri.buis@kncvtbc.org
Click to copy link of this headerMenu